[ad_1]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) posted its quarterly earnings results on Tuesday. The specialty pharmaceutical company reported ($9.07) earnings per share for the quarter, missing analysts’ consensus estimates of ($5.61) by ($3.46). Jazz Pharmaceuticals had a return on equity of 26.62% and a net margin of 11.86%.
[ad_2]
Source link
Jazz Pharmaceuticals (NASDAQ:JAZZ) Announces Earnings Results
